Boditech Med Inc. (KOSDAQ: 206640)

Market Cap	384.59B
Revenue (ttm)	141.86B
Net Income (ttm)	27.30B
Shares Out	21.98M
EPS (ttm)	1,242.03
PE Ratio	14.09
Forward PE	11.33
Dividend	200.00 (1.15%)
Ex-Dividend Date	Mar 29, 2024

Volume	93,747
Average Volume	126,115
Open	17,390
Previous Close	17,400
Day's Range	17,250 - 17,650
52-Week Range	13,350 - 21,050
Beta	-0.65
RSI	56.38
Earnings Date	Feb 19, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1998
• Employees: 491
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2023, Boditech Med's revenue was 134.22 billion, an increase of 13.67% compared to the previous year's 118.08 billion. Earnings were 25.95 billion, an increase of 7.43%.